Eirini Vasilopoulos

Vasilopoulos is the Co-Founder and Chief Executive Officer of PharmaPath, a role they have held since 2022. They are also a Partner at Vamare, a position they have held since 2014. They previously led Product Development at Specifar SA from 2002 to 2011 and headed EU Scientific Affairs at Specifar SA / Watson group from 2011 to 2012. They also served as Head, R&D site at Specifar S.A (an Actavis Company) in 2013, and contributed to Innovis Pharma's Scientific Affairs from 2017 to 2021. They earned a Pharmaceutical Science degree from the University of Patras (1997–2002) and an MSc in Biopharmacy from King's College London (2002–2003).